FDA grants approval to fosamprenavir calcium.
D000284:Administration, Oral; D002219:Carbamates; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D005663:Furans; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D010755:Organophosphates / Q000008:administration & dosage / Q000009:adverse effects; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects; D014481:United States; D014486:United States Food and Drug Administration
D002219:Carbamates; D005663:Furans; D017320:HIV Protease Inhibitors; D010755:Organophosphates; D013449:Sulfonamides; C426859:fosamprenavir